Multidistrict litigation is a process that the United States District Court uses to “centralize complex lawsuits for pre-trial proceedings.”[i]
The process is used because there are multiple plaintiffs with a common set of questions to be addressed at the same time. However, each lawsuit remains individual and separate, as well as the allocation of funds and an award to the plaintiff should they win.
Multidistrict litigations cover a wide variety of cases, including defective drugs or devices, which is the primary specialty and focus of the Michael Brady Lynch Firm.
For example, one of the most recent litigations The Michael Brady Lynch Firm was involved in settling was the Pradaxa litigation, which was a multidistrict litigation that settled around $650 million to compensate Pradaxa bleeding victims.[ii]
The difference between multidistrict litigation cases and class actions is that multidistrict litigation cases are filed by individuals who have suffered from the same type of injury by the same product or device, and the allocation of injury may be on different degrees or levels sufficient for compensation.
If you or a loved one has been injured by a defective drug or device, please call the Michael Brady Lynch Firm at 888-585-5970.
[i] “Multidistrict Litigation” https://www.consumersafety.org/resources/multidistrict-litigation/
[ii] “Pradaxa Lawsuit” https://www.consumersafety.org/drug-lawsuits/pradaxa/